You are here

Vascular Assessments in Breast Cancer Survivors Taking Aromatase Inhibitors

Workflow State: 
Approved
Type of proposal: 
Participant recruitment (what is this?)
Does this project have funding?: 
Yes

Researcher Information

First name: 
Anne
Last name: 
Blaes
Degree: 
M.D., M.S.
Work phone number: 
(612) 626-8138

Institution Information

University of Minnesota
420 Delaware Street, S.E.
55455 Minneapolis , MN
United States

Project Information

List of Collaborators: 
Douglas Yee Heather Beckwith David Potter Daniel Duprez Rachel Vogel Anna Solovey Bob Hebbel
Number of Participants Needed: 
50
Inclusion and Exclusion Criteria: 
Inclusion Criteria: Group One • History of estrogen or progesterone positive breast cancer • Postmenopausal • Planned prescription of an aromatase inhibitor as a part of their treatment for breast cancer • No known history of myocardial infarction • No known history of congestive heart failure • No known history of a cardiac catheterization requiring intervention (i.e. stent placement) • Not taking antihypertensives or cholesterol lowering medications • Not on active chemotherapy or radiation Inclusion Criteria for triple negative breast cancer survivors • History of estrogen and progesterone negative breast cancer • Postmenopausal women • No known history of myocardial infarction • No known history of congestive heart failure • No known history of a cardiac catheterization requiring intervention (i.e. stent placement) • Not taking antihypertensives or cholesterol lowering medications • Within three months of completing surgery, chemotherapy, radiation • Not on active chemotherapy, radiation

Project Details

Primary Area of Study: 
IRB Approval: 
Yes
Legacy Date Received: 
2013-10-10 13:11:03